NextRNA – Talk Bio

Actionable Insights Powered by AI

Bayer and NextRNA Therapeutics Collaborate on $547 Million Deal to Develop Innovative Cancer Therapies Targeting Long Non-Coding RNAs

Bayer, NextRNA Therapeutics, lncRNA, small molecules, cancer, oncology, partnership, drug development